These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 26809243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
    Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, Münchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Bötzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Höglinger GU, PROMESA Study Group.
    Lancet Neurol; 2019 Aug; 18(8):724-735. PubMed ID: 31278067
    [Abstract] [Full Text] [Related]

  • 3. mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.
    Palma JA, Martinez J, Millar Vernetti P, Ma T, Perez MA, Zhong J, Qian Y, Dutta S, Maina KN, Siddique I, Bitan G, Ades-Aron B, Shepherd TM, Kang UJ, Kaufmann H.
    Mov Disord; 2022 Apr; 37(4):778-789. PubMed ID: 35040506
    [Abstract] [Full Text] [Related]

  • 4. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.
    Koh SH, Lee SM, Kim HY, Lee KY, Lee YJ, Kim HT, Kim J, Kim MH, Hwang MS, Song C, Yang KW, Lee KW, Kim SH, Kim OH.
    Neurosci Lett; 2006 Mar 06; 395(2):103-7. PubMed ID: 16356650
    [Abstract] [Full Text] [Related]

  • 5. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T, Winge K, Rasmussen NB, Bahl JM, Tanassi J, Agander TK, Hyde TM, Pakkenberg B.
    J Neurochem; 2016 Jan 06; 136(1):172-85. PubMed ID: 26465922
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study.
    Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, Tolosa E, Cardozo A, Dizdar N, Rascol O, Slaoui T, Growth-Hormone MSA Study Group, European MSA Study Group.
    Mov Disord; 2007 Jun 15; 22(8):1138-44. PubMed ID: 17469198
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats.
    Xie J, Jiang L, Zhang T, Jin Y, Yang D, Chen F.
    Neurosci Lett; 2010 Jul 19; 479(1):26-30. PubMed ID: 20471452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
    Reznichenko L, Kalfon L, Amit T, Youdim MB, Mandel SA.
    Neurodegener Dis; 2010 Jul 19; 7(4):219-31. PubMed ID: 20197647
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA, Ecroyd H, Dehle FC, Musgrave IF, Carver JA.
    J Mol Biol; 2009 Sep 25; 392(3):689-700. PubMed ID: 19616561
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies.
    Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Pavy-Le Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner WG.
    Neurobiol Dis; 2014 Jul 25; 67():133-9. PubMed ID: 24727096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.